{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:08Z","timestamp":1772119688459,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Prostate cancer (PCa) is the second most frequent cancer type in the male population over 66 years. Curcumin is a polyphenolic natural compound extract from the rhizomes of\n                      <jats:italic>Curcuma longa<\/jats:italic>\n                      Linn (\n                      <jats:italic>Zingiberaceae<\/jats:italic>\n                      family) which showed important anticancer effects by inhibiting cell proliferation and inducing apoptosis in several cancer types. Recently, some studies reported that oral curcumin lowered PSA levels, but it did not modify the clinical outcomes in patients with prostate cancer who received intermittent androgen deprivation (IAD). Other studies reported that high concentrations of curcumin were toxic for patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this study we showed that low doses of curcumin can induce senescence-like effects in 22Rv1 cell line while higher concentrations have cytotoxic effects. Five,15 and 30 \u00b5M curcumin blocked cell cycle in G2\/M phase but only 15 and 30 \u00b5M curcumin induced cell death. In addition, an increased expression of p21, a known senescence marker, was detected in 22Rv1 cells treated with curcumin in every experimental condition. However, the expression of p16, another known senescence marker, increased only to 30 \u00b5M curcumin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the context of personalized approach in PCa care, we suggest that the appropriate concentration of curcumin used in combination with radiotherapy or with androgen deprivation therapy (ADT) could be taken into consideration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11033-025-10448-9","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T10:45:15Z","timestamp":1743245115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line"],"prefix":"10.1007","volume":"52","author":[{"given":"Giovanni","family":"Tossetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Fantone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Marinelli","family":"Busilacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Marzioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Mazzucchelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"2","key":"10448_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1158\/1055-9965.EPI-23-1034","volume":"33","author":"J Jiang","year":"2024","unstructured":"Jiang J, Chen B, Tang B, Yang J, Zhang T, Li J, Tan D, Wei Q (2024) Trends of prostate cancer morbidity in Low-Incidence countries from 1990\u20132019. Cancer Epidemiol Biomarkers Prev 33(2):186\u2013195. https:\/\/doi.org\/10.1158\/1055-9965.EPI-23-1034","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10448_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63\u201389. https:\/\/doi.org\/10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"10448_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.02.011","author":"T Neerhut","year":"2024","unstructured":"Neerhut T, Grills R, Lynch R, Preece PD, McLeod K (2024) Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review. Urol Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2024.02.011","journal-title":"Urol Oncol"},{"key":"10448_CR4","doi-asserted-by":"publisher","unstructured":"Fung KFK, Cazzato RL, Tricard T, Marini PDE, Bertucci G, Autrusseau PA et al (2024) MR-Guided transurethral ultrasound ablation (TULSA)-An emerging minimally invasive treatment option for localised prostate cancer. https:\/\/doi.org\/10.1007\/s00270-024-03696-y. Cardiovasc Intervent Radiol","DOI":"10.1007\/s00270-024-03696-y"},{"key":"10448_CR5","doi-asserted-by":"publisher","unstructured":"Campagna R, Pozzi V, Spinelli G, Sartini D, Milanese G, Galosi AB, Emanuelli M (2021) The utility of nicotinamide N-Methyltransferase as a potential biomarker to predict the oncological outcomes for urological cancers: an update. Biomolecules 11(8). https:\/\/doi.org\/10.3390\/biom11081214","DOI":"10.3390\/biom11081214"},{"key":"10448_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1464-410X.2012.11215.x","volume":"6","author":"F Schroder","year":"2012","unstructured":"Schroder F, Crawford ED, Axcrona K, Payne H, Keane TE (2012) Androgen deprivation therapy: past, present and future. BJU Int 109 Suppl 6:1\u201312. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11215.x","journal-title":"BJU Int 109 Suppl"},{"issue":"16","key":"10448_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1080\/14656566.2023.2244415","volume":"24","author":"M Mitsogianni","year":"2023","unstructured":"Mitsogianni M, Papatsoris A, Bala VM, Issa H, Moussa M, Mitsogiannis I (2023) An overview of hormonal directed pharmacotherapy for the treatment of prostate cancer. Expert Opin Pharmacother 24(16):1765\u20131774. https:\/\/doi.org\/10.1080\/14656566.2023.2244415","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"10448_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5694\/mja2.51722","volume":"217","author":"IS Williams","year":"2022","unstructured":"Williams IS, McVey A, Perera S, O\u2019Brien JS, Kostos L, Chen K et al (2022) Modern paradigms for prostate cancer detection and management. Med J Aust 217(8):424\u2013433. https:\/\/doi.org\/10.5694\/mja2.51722","journal-title":"Med J Aust"},{"issue":"1","key":"10448_CR9","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.1038\/s41467-022-33069-3","volume":"13","author":"M Marklund","year":"2022","unstructured":"Marklund M, Schultz N, Friedrich S, Berglund E, Tarish F, Tanoglidi A et al (2022) Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones. Nat Commun 13(1):5475. https:\/\/doi.org\/10.1038\/s41467-022-33069-3","journal-title":"Nat Commun"},{"key":"10448_CR10","doi-asserted-by":"publisher","first-page":"104286","DOI":"10.1016\/j.critrevonc.2024.104286","volume":"196","author":"X Xiong","year":"2024","unstructured":"Xiong X, Zhang S, Zheng W, Liao X, Yang J, Xu H, Hu S, Wei Q, Yang L (2024) Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and bayesian network analysis. Crit Rev Oncol Hematol 196:104286. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104286","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"10448_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.trecan.2023.06.009","volume":"9","author":"G Gebrael","year":"2023","unstructured":"Gebrael G, Fortuna GG, Sayegh N, Swami U, Agarwal N (2023) Advances in the treatment of metastatic prostate cancer. Trends Cancer 9(10):840\u2013854. https:\/\/doi.org\/10.1016\/j.trecan.2023.06.009","journal-title":"Trends Cancer"},{"issue":"3","key":"10448_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/CCO.0000000000001035","volume":"36","author":"T Gourdin","year":"2024","unstructured":"Gourdin T (2024) Highlighting recent progress in the treatment of men with advanced prostate cancer. Curr Opin Oncol 36(3):174\u2013179. https:\/\/doi.org\/10.1097\/CCO.0000000000001035","journal-title":"Curr Opin Oncol"},{"key":"10448_CR13","doi-asserted-by":"publisher","unstructured":"Berben L, Floris G, Wildiers H, Hatse S (2021) Cancer and aging: two tightly interconnected biological processes. Cancers (Basel) 13(6). https:\/\/doi.org\/10.3390\/cancers13061400","DOI":"10.3390\/cancers13061400"},{"issue":"8","key":"10448_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40266-019-00677-6","volume":"36","author":"M Boukovala","year":"2019","unstructured":"Boukovala M, Spetsieris N, Efstathiou E (2019) Systemic treatment of prostate cancer in elderly patients: current role and safety considerations of Androgen-Targeting strategies. Drugs Aging 36(8):701\u2013717. https:\/\/doi.org\/10.1007\/s40266-019-00677-6","journal-title":"Drugs Aging"},{"key":"10448_CR15","doi-asserted-by":"publisher","first-page":"e390396","DOI":"10.1200\/EDBK_390396","volume":"43","author":"LS Graham","year":"2023","unstructured":"Graham LS, Lin JK, Lage DE, Kessler ER, Parikh RB, Morgans AK (2023) Management of prostate cancer in older adults. Am Soc Clin Oncol Educ Book 43:e390396. https:\/\/doi.org\/10.1200\/EDBK_390396","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"10448_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/13685538.2022.2091130","volume":"25","author":"J Jonusas","year":"2022","unstructured":"Jonusas J, Drevinskaite M, Patasius A, Kincius M, Janulionis E, Smailyte G (2022) Androgen-deprivation therapy and risk of death from cardio-vascular disease in prostate cancer patients: a nationwide Lithuanian population-based cohort study. Aging Male 25(1):173\u2013179. https:\/\/doi.org\/10.1080\/13685538.2022.2091130","journal-title":"Aging Male"},{"key":"10448_CR17","doi-asserted-by":"publisher","unstructured":"Tossetta G, Fantone S, Giannubilo SR, Marzioni D (2021) The multifaced actions of Curcumin in pregnancy outcome. Antioxid (Basel) 10(1). https:\/\/doi.org\/10.3390\/antiox10010126","DOI":"10.3390\/antiox10010126"},{"key":"10448_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fendo.2019.00768","volume":"10","author":"J Perugini","year":"2019","unstructured":"Perugini J, Di Mercurio E, Tossetta G, Severi I, Monaco F, Reguzzoni M et al (2019) Biological effects of ciliary neurotrophic factor on hMADS adipocytes. Front Endocrinol (Lausanne) 10:768. https:\/\/doi.org\/10.3389\/fendo.2019.00768","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10448_CR19","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/ptr.6054","volume":"32","author":"V Soleimani","year":"2018","unstructured":"Soleimani V, Sahebkar A, Hosseinzadeh H (2018) Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review. Phytother Res 32(6):985\u2013995. https:\/\/doi.org\/10.1002\/ptr.6054","journal-title":"Phytother Res"},{"issue":"11","key":"10448_CR20","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.bcp.2007.02.006","volume":"73","author":"L Best","year":"2007","unstructured":"Best L, Elliott AC, Brown PD (2007) Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem Pharmacol 73(11):1768\u20131775. https:\/\/doi.org\/10.1016\/j.bcp.2007.02.006","journal-title":"Biochem Pharmacol"},{"key":"10448_CR21","doi-asserted-by":"publisher","unstructured":"Den Hartogh DJ, Gabriel A, Tsiani E (2020) Antidiabetic properties of Curcumin I: evidence from in vitro studies. Nutrients 12(1). https:\/\/doi.org\/10.3390\/nu12010118","DOI":"10.3390\/nu12010118"},{"issue":"1","key":"10448_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00441-022-03658-1","volume":"390","author":"G Tossetta","year":"2022","unstructured":"Tossetta G, Fantone S, Busilacchi EM, Di Simone N, Giannubilo SR, Scambia G, Giordano A, Marzioni D (2022) Modulation of matrix metalloproteases by ciliary neurotrophic factor in human placental development. Cell Tissue Res 390(1):113\u2013129. https:\/\/doi.org\/10.1007\/s00441-022-03658-1","journal-title":"Cell Tissue Res"},{"key":"10448_CR23","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.2147\/CMAR.S244384","volume":"12","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang C, Ren Z, Zhang F, Xu J, Zhang X, Zheng H (2020) Curcumin affects gastric cancer cell migration, invasion and cytoskeletal remodeling through Gli1-beta-Catenin. Cancer Manag Res 12:3795\u20133806. https:\/\/doi.org\/10.2147\/CMAR.S244384","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10448_CR24","doi-asserted-by":"publisher","first-page":"e12458","DOI":"10.1111\/cpr.12458","volume":"51","author":"S Man","year":"2018","unstructured":"Man S, Zhang L, Cui J, Yang L, Ma L, Gao W (2018) Curcumin enhances the anti-cancer effects of Paris saponin II in lung cancer cells. Cell Prolif 51(4):e12458. https:\/\/doi.org\/10.1111\/cpr.12458","journal-title":"Cell Prolif"},{"key":"10448_CR25","doi-asserted-by":"publisher","first-page":"22146","DOI":"10.1038\/srep22146","volume":"6","author":"J Wang","year":"2016","unstructured":"Wang J, Zhang J, Zhang CJ, Wong YK, Lim TK, Hua ZC et al (2016) In situ proteomic profiling of Curcumin targets in HCT116 colon cancer cell line. Sci Rep 6:22146. https:\/\/doi.org\/10.1038\/srep22146","journal-title":"Sci Rep"},{"issue":"3","key":"10448_CR26","doi-asserted-by":"publisher","first-page":"e2331","DOI":"10.17795\/ijcp2331","volume":"8","author":"Z Khazaei Koohpar","year":"2015","unstructured":"Khazaei Koohpar Z, Entezari M, Movafagh A, Hashemi M (2015) Anticancer activity of Curcumin on human breast adenocarcinoma: role of Mcl-1 gene. Iran J Cancer Prev 8(3):e2331. https:\/\/doi.org\/10.17795\/ijcp2331","journal-title":"Iran J Cancer Prev"},{"issue":"8","key":"10448_CR27","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s12272-013-0311-3","volume":"37","author":"Y Zhan","year":"2014","unstructured":"Zhan Y, Chen Y, Liu R, Zhang H, Zhang Y (2014) Potentiation of Paclitaxel activity by Curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling. Arch Pharm Res 37(8):1086\u20131095. https:\/\/doi.org\/10.1007\/s12272-013-0311-3","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10448_CR28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11033-022-08052-2","volume":"50","author":"D Marzioni","year":"2023","unstructured":"Marzioni D, Mazzucchelli R, Fantone S, Tossetta G (2023) NRF2 modulation in TRAMP mice: an in vivo model of prostate cancer. Mol Biol Rep 50(1):873\u2013881. https:\/\/doi.org\/10.1007\/s11033-022-08052-2","journal-title":"Mol Biol Rep"},{"key":"10448_CR29","doi-asserted-by":"publisher","unstructured":"Tossetta G, Fantone S, Marzioni D, Mazzucchelli R (2023) Role of natural and synthetic compounds in modulating NRF2\/KEAP1 signaling pathway in prostate cancer. Cancers (Basel) 15(11). https:\/\/doi.org\/10.3390\/cancers15113037","DOI":"10.3390\/cancers15113037"},{"key":"10448_CR30","doi-asserted-by":"publisher","unstructured":"Tossetta G, Fantone S, Goteri G, Giannubilo SR, Ciavattini A, Marzioni D (2023) The role of NQO1 in ovarian cancer. Int J Mol Sci 24(9). https:\/\/doi.org\/10.3390\/ijms24097839","DOI":"10.3390\/ijms24097839"},{"issue":"5","key":"10448_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jnci\/85.5.394","volume":"85","author":"TG Pretlow","year":"1993","unstructured":"Pretlow TG, Wolman SR, Micale MA, Pelley RJ, Kursh ED, Resnick MI et al (1993) Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst 85(5):394\u2013398. https:\/\/doi.org\/10.1093\/jnci\/85.5.394","journal-title":"J Natl Cancer Inst"},{"key":"10448_CR32","doi-asserted-by":"publisher","unstructured":"Sramkoski RM, Pretlow TG 2nd, Giaconia JM, Pretlow TP, Schwartz S, Sy MS et al (1999) A new human prostate carcinoma cell line, 22Rv1. Vitro Cell Dev Biol Anim 35(7):403\u2013409. https:\/\/doi.org\/10.1007\/s11626-999-0115-4","DOI":"10.1007\/s11626-999-0115-4"},{"issue":"2","key":"10448_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/pros.2990230206","volume":"23","author":"AG Carroll","year":"1993","unstructured":"Carroll AG, Voeller HJ, Sugars L, Gelmann EP (1993) p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23(2):123\u2013134. https:\/\/doi.org\/10.1002\/pros.2990230206","journal-title":"Prostate"},{"issue":"3","key":"10448_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jsbmb.2004.07.004","volume":"92","author":"A Hartel","year":"2004","unstructured":"Hartel A, Didier A, Ulbrich SE, Wierer M, Meyer HH (2004) Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes. J Steroid Biochem Mol Biol 92(3):187\u2013197. https:\/\/doi.org\/10.1016\/j.jsbmb.2004.07.004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10448_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2008.04.053","volume":"270","author":"X Wang","year":"2008","unstructured":"Wang X, Tryndyak V, Apostolov EO, Yin X, Shah SV, Pogribny IP, Basnakian AG (2008) Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on endog expression regulated by promoter methylation. Cancer Lett 270(1):132\u2013143. https:\/\/doi.org\/10.1016\/j.canlet.2008.04.053","journal-title":"Cancer Lett"},{"issue":"4","key":"10448_CR36","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/cas.13517","volume":"109","author":"H Ide","year":"2018","unstructured":"Ide H, Lu Y, Noguchi T, Muto S, Okada H, Kawato S, Horie S (2018) Modulation of AKR1C2 by Curcumin decreases testosterone production in prostate cancer. Cancer Sci 109(4):1230\u20131238. https:\/\/doi.org\/10.1111\/cas.13517","journal-title":"Cancer Sci"},{"issue":"3","key":"10448_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/ijo.2011.905","volume":"38","author":"MH Teiten","year":"2011","unstructured":"Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M, Diederich M (2011) Anti-proliferative potential of Curcumin in androgen-dependent prostate cancer cells occurs through modulation of the wingless signaling pathway. Int J Oncol 38(3):603\u2013611. https:\/\/doi.org\/10.3892\/ijo.2011.905","journal-title":"Int J Oncol"},{"issue":"6","key":"10448_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/omi.2011.0136","volume":"16","author":"MH Teiten","year":"2012","unstructured":"Teiten MH, Gaigneaux A, Chateauvieux S, Billing AM, Planchon S, Fack F et al (2012) Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines. OMICS 16(6):289\u2013300. https:\/\/doi.org\/10.1089\/omi.2011.0136","journal-title":"OMICS"},{"key":"10448_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gene.2017.08.008","volume":"631","author":"T Liu","year":"2017","unstructured":"Liu T, Chi H, Chen J, Chen C, Huang Y, Xi H, Xue J, Si Y (2017) Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by CeRNA effect of miR-145 and lncRNA-ROR. Gene 631:29\u201338. https:\/\/doi.org\/10.1016\/j.gene.2017.08.008","journal-title":"Gene"},{"issue":"1","key":"10448_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/gtmb.2017.0179","volume":"22","author":"H Zhang","year":"2018","unstructured":"Zhang H, Zheng J, Shen H, Huang Y, Liu T, Xi H, Chen C (2018) Curcumin suppresses in vitro proliferation and invasion of human prostate cancer stem cells by modulating DLK1-DIO3 imprinted gene cluster MicroRNAs. Genet Test Mol Biomarkers 22(1):43\u201350. https:\/\/doi.org\/10.1089\/gtmb.2017.0179","journal-title":"Genet Test Mol Biomarkers"},{"key":"10448_CR41","doi-asserted-by":"publisher","unstructured":"Wagner KD, Wagner N (2022) The senescence markers p16INK4A, p14ARF\/p19ARF, and p21 in organ development and homeostasis. Cells 11(12). https:\/\/doi.org\/10.3390\/cells11121966","DOI":"10.3390\/cells11121966"},{"key":"10448_CR42","doi-asserted-by":"publisher","first-page":"1049888","DOI":"10.3389\/fonc.2022.1049888","volume":"12","author":"Y Nan","year":"2022","unstructured":"Nan Y, Su H, Zhou B, Liu S (2022) The function of natural compounds in important anticancer mechanisms. Front Oncol 12:1049888. https:\/\/doi.org\/10.3389\/fonc.2022.1049888","journal-title":"Front Oncol"},{"key":"10448_CR43","doi-asserted-by":"publisher","unstructured":"Zoi V, Galani V, Lianos GD, Voulgaris S, Kyritsis AP, Alexiou GA (2021) The role of Curcumin in cancer treatment. Biomedicines 9(9). https:\/\/doi.org\/10.3390\/biomedicines9091086","DOI":"10.3390\/biomedicines9091086"},{"key":"10448_CR44","doi-asserted-by":"publisher","unstructured":"Ali Abdalla YO, Subramaniam B, Nyamathulla S, Shamsuddin N, Arshad NM, Mun KS, Awang K, Nagoor NH (2022) Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade. J Trop Med 2022: 5794350. https:\/\/doi.org\/10.1155\/2022\/5794350","DOI":"10.1155\/2022\/5794350"},{"key":"10448_CR45","doi-asserted-by":"publisher","unstructured":"Bacchetti T, Campagna R, Sartini D, Cecati M, Morresi C, Bellachioma L et al (2022) C. spinosa L. Subsp. Rupestris phytochemical profile and effect on oxidative stress in normal and cancer cells. Molecules 27(19). https:\/\/doi.org\/10.3390\/molecules27196488","DOI":"10.3390\/molecules27196488"},{"issue":"7","key":"10448_CR46","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/carcin\/bgg082","volume":"24","author":"JH Woo","year":"2003","unstructured":"Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH et al (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome C and Inhibition of Akt. Carcinogenesis 24(7):1199\u20131208. https:\/\/doi.org\/10.1093\/carcin\/bgg082","journal-title":"Carcinogenesis"},{"key":"10448_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biocel.2016.02.014","volume":"74","author":"G Mosieniak","year":"2016","unstructured":"Mosieniak G, Sliwinska MA, Przybylska D, Grabowska W, Sunderland P, Bielak-Zmijewska A, Sikora E (2016) Curcumin-treated cancer cells show mitotic disturbances leading to growth arrest and induction of senescence phenotype. Int J Biochem Cell Biol 74:33\u201343. https:\/\/doi.org\/10.1016\/j.biocel.2016.02.014","journal-title":"Int J Biochem Cell Biol"},{"issue":"22","key":"10448_CR48","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.7150\/jca.45176","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Wu X, Al Rudaisat M, Song Y, Cheng H (2020) Curcumin induces G2\/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells. J Cancer 11(22):6704\u20136715. https:\/\/doi.org\/10.7150\/jca.45176","journal-title":"J Cancer"},{"issue":"11","key":"10448_CR49","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.mocell.2024.100113","volume":"47","author":"J Yan","year":"2024","unstructured":"Yan J, Chen S, Yi Z, Zhao R, Zhu J, Ding S, Wu J (2024) The role of p21 in cellular senescence and aging-related diseases. Mol Cells 47(11):100113. https:\/\/doi.org\/10.1016\/j.mocell.2024.100113","journal-title":"Mol Cells"},{"issue":"3","key":"10448_CR50","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1128\/MCB.19.3.2109","volume":"19","author":"GH Stein","year":"1999","unstructured":"Stein GH, Drullinger LF, Soulard A, Dulic V (1999) Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19(3):2109\u20132117. https:\/\/doi.org\/10.1128\/MCB.19.3.2109","journal-title":"Mol Cell Biol"},{"key":"10448_CR51","doi-asserted-by":"publisher","first-page":"1189015","DOI":"10.3389\/fonc.2023.1189015","volume":"13","author":"S Xiao","year":"2023","unstructured":"Xiao S, Qin D, Hou X, Tian L, Yu Y, Zhang R et al (2023) Cellular senescence: a double-edged sword in cancer therapy. Front Oncol 13:1189015. https:\/\/doi.org\/10.3389\/fonc.2023.1189015","journal-title":"Front Oncol"},{"issue":"6","key":"10448_CR52","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pros.23766","volume":"79","author":"YH Choi","year":"2019","unstructured":"Choi YH, Han DH, Kim SW, Kim MJ, Sung HH, Jeon HG et al (2019) A randomized, double-blind, placebo-controlled trial to evaluate the role of Curcumin in prostate cancer patients with intermittent androgen deprivation. Prostate 79(6):614\u2013621. https:\/\/doi.org\/10.1002\/pros.23766","journal-title":"Prostate"},{"issue":"2","key":"10448_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000441148","volume":"90","author":"H Mahammedi","year":"2016","unstructured":"Mahammedi H, Planchat E, Pouget M, Durando X, Cure H, Guy L et al (2016) The new combination docetaxel, prednisone and Curcumin in patients with Castration-Resistant prostate cancer: A pilot phase II study. Oncology 90(2):69\u201378. https:\/\/doi.org\/10.1159\/000441148","journal-title":"Oncology"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10448-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10448-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10448-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:32:26Z","timestamp":1766853146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10448-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10448"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10448-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5448614\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}